Cumberland Pharmaceuticals Inc. Stock-Based Compensation
Cumberland Pharmaceuticals Inc. (CPIX) reported Stock-Based Compensation of $184.71 thousand for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-07
- Cumberland Pharmaceuticals Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $77.87K, a 3.50% decline year-over-year.
- Cumberland Pharmaceuticals Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $106.84K, a 43.97% increase year-over-year.
- Cumberland Pharmaceuticals Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $172.16K, a 130.12% increase year-over-year.
- Cumberland Pharmaceuticals Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $81.26K, a 6.40% increase year-over-year.
- Cumberland Pharmaceuticals Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $408.32K, a 35.25% increase from fiscal 2024.
- Cumberland Pharmaceuticals Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $301.89K, a 17.30% decline from fiscal 2023.
- Cumberland Pharmaceuticals Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $365.04K, a 18.43% decline from fiscal 2022.
- Cumberland Pharmaceuticals Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $447.50K, a 39.68% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 6 month as first filed | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 9 month as first filed | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|---|---|
| 2026-06-30 | $77.87K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $184.71K 10-Q · filed 2026-08-07 | $356.87K derived: sum of 3 quarters · filed 2026-08-07 | $438.13K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2026-03-31 | $106.84K 10-Q · filed 2026-05-08 | $279.00K derived: sum of 2 quarters · filed 2026-05-08 | $360.26K derived: sum of 3 quarters · filed 2026-05-08 | $440.95K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-12-31 | $172.16K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $253.42K derived: sum of 2 quarters · filed 2026-03-09 | $334.11K derived: sum of 3 quarters · filed 2026-08-07 | $408.32K 10-K · filed 2026-03-09 | ||
| 2025-09-30 | $81.26K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $161.95K derived: sum of 2 quarters · filed 2026-08-07 | $236.16K 10-Q · filed 2025-11-07 | $310.97K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-06-30 | $80.69K derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07 | $154.90K 10-Q · filed 2026-08-07 | $229.71K derived: sum of 3 quarters · filed 2026-08-07 | $306.08K derived: sum of 4 quarters · filed 2026-08-07 | ||
| 2025-03-31 | $74.21K 10-Q · filed 2026-05-08 | $149.02K derived: sum of 2 quarters · filed 2026-05-08 | $225.40K derived: sum of 3 quarters · filed 2026-05-08 | $297.35K derived: sum of 4 quarters · filed 2026-05-08 | ||
| 2024-12-31 | $74.81K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-09 | $151.18K derived: sum of 2 quarters · filed 2026-03-09 | $223.14K derived: sum of 3 quarters · filed 2026-03-09 | $301.89K 10-K · filed 2026-03-09 | ||
| 2024-09-30 | $76.37K derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07 | $148.33K derived: sum of 2 quarters · filed 2025-11-07 | $227.08K 10-Q · filed 2025-11-07 | $320.98K derived: sum of 4 quarters · filed 2025-11-07 | ||
| 2024-06-30 | $71.96K derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08 | $150.71K 10-Q · filed 2025-08-08 | $244.61K derived: sum of 3 quarters · filed 2025-08-08 | $327.72K derived: sum of 4 quarters · filed 2025-08-08 | ||
| 2024-03-31 | $78.75K 10-Q · filed 2025-05-09 | $172.65K derived: sum of 2 quarters · filed 2025-05-09 | $255.76K derived: sum of 3 quarters · filed 2025-05-09 | $353.64K derived: sum of 4 quarters · filed 2025-05-09 | ||
| 2023-12-31 | $93.89K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-07 | $177.01K derived: sum of 2 quarters · filed 2025-03-07 | $274.88K derived: sum of 3 quarters · filed 2025-03-07 | $365.04K 10-K · filed 2025-03-07 | ||
| 2023-09-30 | $83.11K derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-08 | $180.99K derived: sum of 2 quarters · filed 2024-11-08 | $271.15K 10-Q · filed 2024-11-08 | $398.05K derived: sum of 4 quarters · filed 2024-11-08 | ||
| 2023-06-30 | $97.88K derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-09 | $188.03K 10-Q · filed 2024-08-09 | $314.94K derived: sum of 3 quarters · filed 2024-08-09 | $503.39K derived: sum of 4 quarters · filed 2024-08-09 | ||
| 2023-03-31 | $90.16K 10-Q · filed 2024-05-10 | $217.06K derived: sum of 2 quarters · filed 2024-05-10 | $405.51K derived: sum of 3 quarters · filed 2024-05-10 | $377.76K derived: sum of 4 quarters · filed 2024-05-10 | ||
| 2022-12-31 | $126.91K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-13 | $315.36K derived: sum of 2 quarters · filed 2024-03-13 | $287.60K derived: sum of 3 quarters · filed 2024-03-13 | $447.50K 10-K · filed 2024-03-13 | ||
| 2022-09-30 | $188.45K derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-13 | $160.70K derived: sum of 2 quarters · filed 2023-11-13 | $320.60K 10-Q · filed 2023-11-13 | $545.38K derived: sum of 4 quarters · filed 2023-11-13 | ||
| 2022-06-30 | -$27.75K derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-11 | $132.15K 10-Q · filed 2023-08-11 | $356.93K derived: sum of 3 quarters · filed 2023-08-11 | $519.10K derived: sum of 4 quarters · filed 2023-08-11 | ||
| 2022-03-31 | $159.90K 10-Q · filed 2023-05-12 | $384.69K derived: sum of 2 quarters · filed 2023-05-12 | $546.85K derived: sum of 3 quarters · filed 2023-05-12 | $738.81K derived: sum of 4 quarters · filed 2023-05-12 | ||
| 2021-12-31 | $224.79K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-13 | $386.95K derived: sum of 2 quarters · filed 2023-03-13 | $578.91K derived: sum of 3 quarters · filed 2023-03-13 | $741.87K 10-K · filed 2023-03-13 | ||
| 2021-09-30 | $162.17K derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-14 | $354.12K derived: sum of 2 quarters · filed 2022-11-14 | $517.08K 10-Q · filed 2022-11-14 | $758.26K derived: sum of 4 quarters · filed 2022-11-14 | ||
| 2021-06-30 | $191.95K derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-12 | $354.91K 10-Q · filed 2022-08-12 | $596.09K derived: sum of 3 quarters · filed 2022-08-12 | $858.51K derived: sum of 4 quarters · filed 2022-08-12 | ||
| 2021-03-31 | $162.96K 10-Q · filed 2022-05-13 | $404.14K derived: sum of 2 quarters · filed 2022-05-13 | $666.55K derived: sum of 3 quarters · filed 2022-05-13 | $944.90K derived: sum of 4 quarters · filed 2022-05-13 | ||
| 2020-12-31 | $241.18K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $503.59K derived: sum of 2 quarters · filed 2022-03-11 | $781.94K derived: sum of 3 quarters · filed 2022-03-11 | $1.05M 10-K · filed 2022-03-11 | ||
| 2020-09-30 | $262.42K derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-12 | $540.76K derived: sum of 2 quarters · filed 2021-11-12 | $805.34K 10-Q · filed 2021-11-12 | $1.18M derived: sum of 4 quarters · filed 2022-03-11 | ||
| 2020-06-30 | $278.35K derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-13 | $542.92K 10-Q · filed 2021-08-13 | $921.00K derived: sum of 3 quarters · filed 2022-03-11 | $1.27M derived: sum of 4 quarters · filed 2022-03-11 | ||
| 2020-03-31 | $264.57K 10-Q · filed 2021-05-14 | $642.65K derived: sum of 2 quarters · filed 2022-03-11 | $989.49K derived: sum of 3 quarters · filed 2022-03-11 | $1.39M derived: sum of 4 quarters · filed 2022-03-11 | ||
| 2019-12-31 | $378.08K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-11 | $724.92K derived: sum of 2 quarters · filed 2022-03-11 | $1.12M derived: sum of 3 quarters · filed 2022-03-11 | $1.49M 10-K · filed 2022-03-11 | ||
| 2019-09-30 | $346.83K derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-13 | $743.38K derived: sum of 2 quarters · filed 2020-11-13 | $1.11M 10-Q · filed 2020-11-13 | $1.47M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-06-30 | $396.55K derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-14 | $760.98K 10-Q · filed 2020-08-14 | $1.12M derived: sum of 3 quarters · filed 2021-03-12 | $1.46M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2019-03-31 | $364.43K 10-Q · filed 2020-05-22 | $723.89K derived: sum of 2 quarters · filed 2021-03-12 | $1.06M derived: sum of 3 quarters · filed 2021-03-12 | $1.39M derived: sum of 4 quarters · filed 2021-03-12 | ||
| 2018-12-31 | $359.46K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-12 | $699.39K derived: sum of 2 quarters · filed 2021-03-12 | $1.03M derived: sum of 3 quarters · filed 2021-03-12 | $1.36M 10-K · filed 2021-03-12 | ||
| 2018-09-30 | $339.93K derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-13 | $666.03K derived: sum of 2 quarters · filed 2019-11-13 | $1.01M 10-Q · filed 2019-11-13 | $1.27M derived: sum of 4 quarters · filed 2020-12-10 | ||
| 2018-06-30 | $326.10K derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-14 | $665.31K 10-Q · filed 2019-08-14 | $931.17K derived: sum of 3 quarters · filed 2020-12-10 | $1.23M derived: sum of 4 quarters · filed 2020-12-10 | ||
| 2018-03-31 | $339.21K 10-Q · filed 2019-05-15 | $605.07K derived: sum of 2 quarters · filed 2020-12-10 | $903.02K derived: sum of 3 quarters · filed 2020-12-10 | $1.20M derived: sum of 4 quarters · filed 2020-12-10 | ||
| 2017-12-31 | $265.87K derived: 8-K 12 month − 10-Q 9 month · filed 2020-12-10 | $563.81K derived: sum of 2 quarters · filed 2020-12-10 | $860.48K derived: sum of 3 quarters · filed 2020-12-10 | $1.12M 8-K · filed 2020-12-10 | ||
| 2017-09-30 | $297.94K derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | $594.61K derived: sum of 2 quarters · filed 2018-11-14 | $849.20K 10-Q · filed 2018-11-14 | $1.08M derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-06-30 | $296.67K derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | $551.25K 10-Q · filed 2018-08-14 | $779.85K derived: sum of 3 quarters · filed 2019-03-12 | $995.13K derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2017-03-31 | $254.59K 10-Q · filed 2018-05-09 | $483.18K derived: sum of 2 quarters · filed 2019-03-12 | $698.46K derived: sum of 3 quarters · filed 2019-03-12 | $931.91K derived: sum of 4 quarters · filed 2019-03-12 | ||
| 2016-12-31 | $228.60K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-12 | $443.88K derived: sum of 2 quarters · filed 2019-03-12 | $677.32K derived: sum of 3 quarters · filed 2019-03-12 | $852.10K 10-K · filed 2019-03-12 | ||
| 2016-09-30 | $215.28K derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-08 | $448.73K derived: sum of 2 quarters · filed 2017-11-08 | $623.50K 10-Q · filed 2017-11-08 | $819.36K derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2016-06-30 | $233.45K derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | $408.23K 10-Q · filed 2017-08-09 | $604.08K derived: sum of 3 quarters · filed 2018-03-09 | $481.13K derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2016-03-31 | $174.78K 10-Q · filed 2017-05-15 | $370.63K derived: sum of 2 quarters · filed 2018-03-09 | $247.68K derived: sum of 3 quarters · filed 2018-03-09 | $550.81K derived: sum of 4 quarters · filed 2018-03-09 | ||
| 2015-12-31 | $195.85K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-09 | $72.90K derived: sum of 2 quarters · filed 2018-03-09 | $376.03K derived: sum of 3 quarters · filed 2018-03-09 | $622.50K 10-K · filed 2018-03-09 | ||
| 2015-09-30 | -$122.95K derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-03 | $180.18K derived: sum of 2 quarters · filed 2016-11-03 | $426.65K 10-Q · filed 2016-11-03 | $646.20K derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2015-06-30 | $303.13K derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-05 | $549.60K 10-Q · filed 2016-08-05 | $769.15K derived: sum of 3 quarters · filed 2017-03-13 | $985.92K derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2015-03-31 | $246.47K 10-Q · filed 2016-05-13 | $466.02K derived: sum of 2 quarters · filed 2017-03-13 | $682.79K derived: sum of 3 quarters · filed 2017-03-13 | $882.38K derived: sum of 4 quarters · filed 2017-03-13 | ||
| 2014-12-31 | $219.54K derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-13 | $436.32K derived: sum of 2 quarters · filed 2017-03-13 | $635.90K derived: sum of 3 quarters · filed 2017-03-13 | $761.66K 10-K · filed 2017-03-13 | ||
| 2014-09-30 | $216.77K derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-06 | $416.36K derived: sum of 2 quarters · filed 2015-11-06 | $542.12K 10-Q · filed 2015-11-06 | $736.27K derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2014-06-30 | $199.59K derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-07 | $325.34K 10-Q · filed 2015-08-07 | $519.49K derived: sum of 3 quarters · filed 2016-03-14 | $695.10K derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2014-03-31 | $125.76K 10-Q · filed 2015-05-15 | $319.91K derived: sum of 2 quarters · filed 2016-03-14 | $495.51K derived: sum of 3 quarters · filed 2016-03-14 | $672.09K derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-12-31 | $194.15K derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-14 | $369.76K derived: sum of 2 quarters · filed 2016-03-14 | $546.33K derived: sum of 3 quarters · filed 2016-03-14 | $674.96K 10-K · filed 2016-03-14 | ||
| 2013-09-30 | $175.61K derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-07 | $352.18K derived: sum of 2 quarters · filed 2014-11-07 | $480.81K 10-Q · filed 2014-11-07 | $560.63K derived: sum of 4 quarters · filed 2015-03-09 | ||
| 2013-06-30 | $176.57K derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-08 | $305.20K 10-Q · filed 2014-08-08 | $385.02K derived: sum of 3 quarters · filed 2015-03-09 | $550.94K derived: sum of 4 quarters · filed 2015-03-09 | ||
| 2013-03-31 | $128.63K 10-Q · filed 2014-05-12 | $208.45K derived: sum of 2 quarters · filed 2015-03-09 | $374.37K derived: sum of 3 quarters · filed 2015-03-09 | $550.77K derived: sum of 4 quarters · filed 2015-03-09 | ||
| 2012-12-31 | $79.82K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-09 | $245.74K derived: sum of 2 quarters · filed 2015-03-09 | $422.15K derived: sum of 3 quarters · filed 2015-03-09 | $636.53K 10-K · filed 2015-03-09 | ||
| 2012-09-30 | $165.92K derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-06 | $342.32K derived: sum of 2 quarters · filed 2013-11-06 | $556.70K 10-Q · filed 2013-11-06 | $455.67K 10-Q · filed 2012-11-02 | $868.16K derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-06-30 | $176.41K derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-09 | $390.79K 10-Q · filed 2013-08-09 | $315.34K 10-Q · filed 2012-08-09 | $702.24K derived: sum of 3 quarters · filed 2014-03-11 | $854.58K derived: sum of 4 quarters · filed 2014-03-11 | |
| 2012-03-31 | $214.38K 10-Q · filed 2013-05-08 | $525.84K derived: sum of 2 quarters · filed 2014-03-11 | $678.17K derived: sum of 3 quarters · filed 2014-03-11 | |||
| 2011-12-31 | $311.45K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-11 | $463.79K derived: sum of 2 quarters · filed 2014-03-11 | $779.30K 10-K · filed 2014-03-11 | |||
| 2011-09-30 | $152.34K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-02 | $467.85K 10-Q · filed 2012-11-02 | ||||
| 2011-06-30 | $315.51K 10-Q · filed 2012-08-09 | |||||
| 2010-12-31 | $265.18K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $450.49K derived: sum of 2 quarters · filed 2013-03-12 | $768.63K 10-K · filed 2013-03-12 | |||
| 2010-09-30 | $185.31K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-07 | $503.45K 10-Q · filed 2011-11-07 | ||||
| 2010-06-30 | $318.14K 10-Q · filed 2011-08-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aardvark Therapeutics, Inc. (AARD) | United States | $0.121B | -1.80 |
| Coya Therapeutics, Inc. (COYA) | United States | $0.121B | -6.35 |
| OnKure Therapeutics, Inc. (OKUR) | United States | $0.119B | -3.13 |
| INOVIO PHARMACEUTICALS, INC. (INO) | United States | $0.125B | -1.35 |
| IMMUNIC, INC. (IMUX) | United States | $0.127B | -1.88 |
| Immuneering Corp (IMRX) | United States | $0.113B | -12.51 |
| Quantum Cyber N.V. (QUCY) | $0.113B | ||
| MEDICINOVA INC (MNOV) | United States | $0.130B | -6.04 |
| BICYCLE THERAPEUTICS PLC (BCYC) | $0.112B | -1.56 | |
| NRX Pharmaceuticals, Inc. (NRXP) | United States | $0.131B | -6.31 |